Publications by authors named "Christopher Wragg"

Claim this Profile
A
Association for Clinical Genomic Science (ACGS) guidelines for the classification of oncogenicity of somatic variants in cancer: recommendations by the UK somatic variant interpretation group (SVIG-UK).
George J Burghel, Joanne Mason, Kevin Baker, Kate Moloney, Claire Holt McKeeve, Christopher Wragg

J Med Genet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group.
Beverley Speight, Helen Hanson, Clare Turnbull, Steven Hardy, James Drummond, Christopher Wragg

Br J Haematol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.
Sebastian Brandner, Alexandra McAleenan, Hayley E Jones, Ashleigh Kernohan, Tomos Robinson, Christopher Wragg

Neuropathol Appl Neurobiol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
Alexandra McAleenan, Hayley E Jones, Ashleigh Kernohan, Tomos Robinson, Lena Schmidt, Christopher Wragg

Cochrane Database Syst Rev· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review.
Sebastian Brandner, Alexandra McAleenan, Claire Kelly, Francesca Spiga, Hung-Yuan Cheng, Christopher Wragg

Neuro Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.
Alexandra McAleenan, Claire Kelly, Francesca Spiga, Ashleigh Kernohan, Hung-Yuan Cheng, Christopher Wragg

Cochrane Database Syst Rev· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia.
Esther Meyer, Keren J Carss, Julia Rankin, John M E Nichols, Detelina Grozeva, Christopher Wragg

Nat Genet· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia.
Esther Meyer, Keren J Carss, Julia Rankin, John M E Nichols, Detelina Grozeva, Christopher Wragg

Nat Genet· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.
Claire Schwab, Sarra L Ryan, Lucy Chilton, Alannah Elliott, James Murray, Christopher Wragg

Blood· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.
Claire Faulkner, Hayley Patricia Ellis, Abigail Shaw, Catherine Penman, Abigail Palmer, Christopher Wragg

J Neuropathol Exp Neurol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers.
Claire Faulkner, Abigail Palmer, Hannah Williams, Christopher Wragg, Harry R Haynes

Br J Neurosurg· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next generation sequencing of chromosomal rearrangements in patients with split-hand/split-foot malformation provides evidence for DYNC1I1 exonic enhancers of DLX5/6 expression in humans.
Hana Lango Allen, Richard Caswell, Weijia Xie, Xiao Xu, Christopher Wragg

J Med Genet· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis